Prezista Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Raltegravir One Thousand Two Hundred vs Darunavir-cb in Immnunosupressed Patients: ROTDIP Study
Condition:   HIV Infections Interventions:   Drug: Experimental: RAL QD;   Drug: Active comparator: DRV/cb Sponsors:   Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud;   Merck Sharp & Dohme Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2019 Category: Research Source Type: clinical trials